Aperçus
Le test MyGenome repose sur un processus de séquençage du génome entier. Cette analyse permet d'identifier les variations génétiques au sein de votre ADN. L'objectif du séquençage du génome est d'obtenir des informations médicales vitales pour vous permettre de prendre soin de vous au mieux.
Recherche par filtre
-
What is Hereditary Cancer?
Cancer is, unfortunately, an exceptionally common disease. Most of us have known someone in our families or friendship circles that have experienced it. Cancer occurs when cells mutate and grow...
What is Hereditary Cancer?
Cancer is, unfortunately, an exceptionally common disease. Most of us have known someone in our families or friendship circles that have experienced it. Cancer occurs when cells mutate and grow...
-
What is a Genetic Disorder?
An exploration of genetic disorders: why do they occur and when is it necessary to seek out testing and treatment? The human genome is a complex set of instructions that...
What is a Genetic Disorder?
An exploration of genetic disorders: why do they occur and when is it necessary to seek out testing and treatment? The human genome is a complex set of instructions that...
-
What's in a Health Report?
Learn how at risk you are from developing health conditions and disease with a whole genome sequencing test from Dante. About Hereditary DiseasesThe future of our health lies deep...
What's in a Health Report?
Learn how at risk you are from developing health conditions and disease with a whole genome sequencing test from Dante. About Hereditary DiseasesThe future of our health lies deep...
Nouvelles de l'entreprise
Le séquençage du génome entier est un test utilisé pour identifier les variations génétiques au sein de votre ADN. L'objectif du séquençage du génome est d'obtenir des informations médicales vitales pour vous permettre de prendre soin de vous au mieux.
-
Dante Genomics launches Avanti Software for a p...
NEW YORK, March 20, 2023 (PR NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, launched today the beta version of Avanti, the Company’s proprietary B2B software for variant...
Dante Genomics launches Avanti Software for a p...
NEW YORK, March 20, 2023 (PR NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, launched today the beta version of Avanti, the Company’s proprietary B2B software for variant...
-
FinancialTimes selected Dante Genomics in the T...
The Financial Times has published its 7th annual ranking of the 1000 fastest-growing companies in Europe. Dante Genomic ranks among the top 25, registering a 250.5% CAGR in revenues between...
FinancialTimes selected Dante Genomics in the T...
The Financial Times has published its 7th annual ranking of the 1000 fastest-growing companies in Europe. Dante Genomic ranks among the top 25, registering a 250.5% CAGR in revenues between...
-
Dante Genomics’ sequencing hub in Dubai receive...
NEW YORK, January 25, 2023 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, announced today that their laboratory in Dubai, which serves as a global hub for the...
Dante Genomics’ sequencing hub in Dubai receive...
NEW YORK, January 25, 2023 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, announced today that their laboratory in Dubai, which serves as a global hub for the...
